3-OMe AG (Cap1) 100mM

Protease K |Creatinase lamp |dNTP |All-purpose nuclease mRNA

Home · Products · Products · mRNA Therapies · mRNA Transcription and Capping · Cap Analogs · 3-OMe AG (Cap1) 100mM ·

100μL: HBP002808-1

1mL: HBP002808-2

10mL: HBP002808-3

100mL: HBP002808-4

Cat. No: HBP002808

Transportation and storage: Store at -20℃ or below, and shipped at ≤0℃.

Technical Support

Cap analogs

Cap analogs are used to cap the 5' end of mRNA in an in vitro synthesis reaction of mRNA. It can replace the natural mRNA cap structure, and has the function of increasing mRNA stability and decreasing immunogenicity. At present, mRNA capping is mainly carried out by in vitro transcription, in which mRNA is prepared by one-step method of co-transcription with cap analogues, which is relatively simple in process and quality control, and is the preferred method for mRNA preparation.

The development of a new cap analogue product with independent intellectual property rights will provide the mRNA industry with cost-effective mRNA preparation raw materials and promote the development of the mRNA industry.

Hzymes Biotech provides a series of GMP-GRADE cap analogues with independent intellectual property rights for different applications in mRNA therapy.

Product Description

This product is used to cap the 5 'end of mRNA to form cap 1 structure during in vitro transcription. Compared with cap 0 structure (Arca and MCAP capped), mRNAs with cap 1 structure are more suitable for mammalian systems and have higher transcriptional efficiency.

Product Information

Product Name	Cat. No	Size
CAP GAG (3'OMe) m7 (3'OMeG) (5') ppp (5') (2'O MeA) pG 100mM Ammonium Solution, GMP grade	HBP002808-1	100 μL
	HBP002808-2	1 mL
	HBP002808-3	10 mL
	HBP002808-4	100 mL